Cargando…
Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes
Ectodysplasin A (EDA) was recently identified as a liver-secreted protein that is increased in the liver and plasma of obese mice and causes skeletal muscle insulin resistance. We assessed if liver and plasma EDA is associated with worsening non-alcoholic fatty liver disease (NAFLD) in obese patient...
Autores principales: | Bayliss, Jacqueline, Ooi, Geraldine J., De Nardo, William, Shah, Yazmin Johari Halim, Montgomery, Magdalene K., McLean, Catriona, Kemp, William, Roberts, Stuart K., Brown, Wendy A., Burton, Paul R., Watt, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970300/ https://www.ncbi.nlm.nih.gov/pubmed/33746906 http://dx.doi.org/10.3389/fendo.2021.642432 |
Ejemplares similares
-
Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients
por: Deng, Xia, et al.
Publicado: (2021) -
Ectodysplasin A/Ectodysplasin A Receptor System and Their Roles in Multiple Diseases
por: Cai, Zhensheng, et al.
Publicado: (2021) -
Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism
por: De Nardo, William, et al.
Publicado: (2022) -
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control
por: Montgomery, Magdalene K., et al.
Publicado: (2022) -
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies
por: Karimkhanloo, Hamzeh, et al.
Publicado: (2023)